Orchard Therapeutics plc Quarterly Other Liabilities, Noncurrent in USD from Q4 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Orchard Therapeutics plc quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2017 to Q3 2023.
  • Orchard Therapeutics plc Other Liabilities, Noncurrent for the quarter ending September 30, 2023 was $8.38M, a 26.3% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $8.38M +$1.74M +26.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.17M +$1.7M +26.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $7.74M +$954K +14.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $7.52M +$1.74M +30.1% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $6.63M +$607K +10.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $6.47M +$316K +5.14% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.78M +$790K +13.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.78M -$787K -12% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $6.03M +$1.9M +46.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $6.15M +$1.98M +47.4% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $5.99M +$2.79M +87% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $6.57M +$2.36M +55.9% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $4.12M -$1.96M -32.2% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $4.17M -$2.85M -40.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.2M -$3.94M -55.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $4.21M -$2.59M -38% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $6.08M Sep 30, 2019 6-K 2019-11-07
Q2 2019 $7.02M Jun 30, 2019 6-K 2019-08-08
Q1 2019 $7.14M Mar 31, 2019 6-K 2019-05-28
Q4 2018 $6.8M +$6.67M +4974% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $134K Dec 31, 2017 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.